Evidence map›Paper›PMID 31337082›Full record

ArticleDiagnostics (Basel, Switzerland)2019

Perspective of Molecular Diagnosis in Healthcare: From Barcode to Pattern Recognition.

Qian He, Mengdi Bao, Kenneth Hass, Wenxia Lin, Peiwu Qin, Ke Du

Abstract read
In one paragraph

Article in Diagnostics (Basel, Switzerland), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Qian HeDepartment of Mechanical Engineering, Rochester Institute of Technology, Rochester, NY 14623, USA.ORCID 0000-0002-2410-9604
Mengdi BaoDepartment of Mechanical Engineering, Rochester Institute of Technology, Rochester, NY 14623, USA.
Kenneth HassDepartment of Mechanical Engineering, Rochester Institute of Technology, Rochester, NY 14623, USA.
Wenxia LinDepartment of QB3, University of California, Berkeley, CA 94720, USA.
Peiwu QinPrecision Medicine and Public Healthcare Research Center, Tsinghua-Berkeley Shenzhen Institute, Shenzhen 518057, China. pwqin@sz.tsinghua.edu.cn.
Ke DuDepartment of Mechanical Engineering, Rochester Institute of Technology, Rochester, NY 14623, USA. ke.du@rit.edu.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Barcode technology has a broad spectrum of applications including healthcare, food security, and environmental monitoring, due to its ability to encode large amounts of information. With the rapid development of modern molecular research, barcodes are utilized as a reporter with different molecular combinations to label many biomolecular targets, including genomic and metabolic elements, even with multiplex targeting. Along with the advancements in barcoded bioassay, the improvements of various designs of barcode components, encoding and decoding strategies, and their portable adoption are indispensable in satisfying multiple purposes, such as medical confirmation and point-of-care (POC) testing. This perspective briefly discusses the current direction and progress of barcodes development and provides a hypothesis for barcoded bioassay in the near future.

Indexed as

barcodebioassayDNAfluorescencegold nanoparticlepoint-of-care (POC)RNA

Identifiers

PMID31337082
PMCPMC6787598

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.